MD, PhD, Professor of Therapeutics and Cardiology, Director, Clinical Investigation Centre, INSERM, Head of Heart Failure and Hypertension Unit, Department of Cardiology, CHU and University Henri Poincaré, Nancy, France.  

Contact: f.zannad@chu-nancy.fr

Faiez Zannad is Professor of Therapeutics and Cardiology.
He is at the Head of the Division of Heart Failure, Hypertension and Preventive Cardiology for the department of Cardiovascular Disease of the Academic Hospital (CHU) in Nancy and the Director of the Clinical Investigation Centre (Inserm-CHU) of Nancy since 1995.

He entered the European Society of Cardiology (ESC) in 1996 and is past Chairman of the European Society of Cardiology (ESC) Working group on Pharmacology and Drug Therapy and past-President of the French Society of Hypertension.

He is the Principal investigator and Member of Steering committees of major large scale trials in human cardiology (RALES, VALIANT, CIBIS, CAPRICORN, EPHESUS, EMPHASIS-HF).

He has served as Co-Editor-in-Chief for Fundamental and Clinical Pharmacology, the official journal of the European Pharmacology Societies Federation (EUPHAR).

He chairs and organises annual international meetings on CardioVascular Clinical Trials (CVCT) and on Biomarkers in Heart Failure.